This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Aug;7(8):417.

doi: 10.1038/nrcardio.2010.93.

Cardiac device implantation risks

Bryony M Mearns

PMID: 20681052
DOI: 10.1038/nrcardio.2010.93

Comment

Cardiac device implantation risks

Bryony M Mearns. Nat Rev Cardiol. 2010 Aug.

. 2010 Aug;7(8):417.

doi: 10.1038/nrcardio.2010.93.

Author

Bryony M Mearns

PMID: 20681052
DOI: 10.1038/nrcardio.2010.93

No abstract available

PubMed Disclaimer

Comment on

Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, Nazarian S, Spragg DD, Sinha S, Halperin H, Tomaselli GF, Berger RD, Calkins H, Henrikson CA. Tompkins C, et al. J Am Coll Cardiol. 2010 May 25;55(21):2376-82. doi: 10.1016/j.jacc.2009.12.056. J Am Coll Cardiol. 2010. PMID: 20488310

References

1. J Am Coll Cardiol. 2010 May 25;55(21):2376-82 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.